Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors

• Main Authors: Chin, T.-M., Boopathy, G.T.K., Man, E.P.S., Clohessy, J.G., Csizmadia, E., Quinlan, M.P., Putti, T., Wan, S.-C., Xie, C., Ali, A., Wai, F.C., Ong, Y.S., Goh, B.-C., Settleman, J., Hong, W., Levantini, E., Tenen, D.G.
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Published: Ivyspring International Publisher 2021
• Subjects: Chloroquine; EGFR mutants; Microtubule dysfunction; NSCLC; Tyrosine kinase inhibitors
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/197870
• Institution: National University of Singapore

10.7150/thno.38729